We tested this hypothesis by performing mixed‐effects logistic regression modelling, which showed a trend towards younger age in patients for whom IVIg prescription was non‐compliant (Table 2 ).
← all excerpts
When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?
1
—
—